Hormone-refractory prostate cancer
Not recruitingStudy Comparing Radium-223 Dichloride with Abiraterone Acetate, Enzalutamide, and Prednisone in Patients with Advanced Prostate Cancer Spread to the Bone
Study Comparing Radium-223 Dichloride with Abiraterone Acetate, Enzalutamide, and Prednisone in Patients with Advanced Prostate Cancer Spread to the Bone
- Disease:Hormone-refractory prostate cancer
- Substances:Abiraterone AcetateEnzalutamide+3
Austria- Participants:18–64 years · 65+ years
- Substances:Abiraterone Acetate













